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Background:  Intracoronary kit+ cardiac stem cells (CSCs) delivery preserves LV function and structure after myocardial infarction (MI). 
The CSC dose for optimal cardiac repair is unknown, thus CSC dose-response studies were performed. 
methods:  PBS (vehicle) or syngeneic CSCs at 0.3, 0.75, 1.5, 3.0, and 6.0 x 106 (M) cells/ rat were given intracoronarily after 4 h of 
reperfusion following a 90 minute coronary occlusion. LV function, morphology, immunohistochemistry, and proliferation were assessed 35 
days later. 
results:  The 6.0 M group had significantly higher post-procedural mortality (Fig. A). Echocardiography showed ejection fraction (EF), 
infarct wall thickening fraction (IW ThF), and LV end-systolic volume (LVESV) were improved significantly in the 4 groups of rats that 
received CSCs at doses of 0.75 M CSCs and higher, but not in those that received PBS or 0.3 M CSCs (Fig. B). Similarly, hemodynamic 
studies revealed LV dP/dtmax, preload adjusted maximal power (PAMP), end-systolic elastance (Ees), and preload recruitable stroke work 
(PRSW) were significantly improved in the 4 higher dose groups, but not in the PBS or low dose group (Fig. C). CSC doses of 0.75 M or 
greater decreased infarct size, increased risk region viable myocardium, reduced collagen content and apotosis, and increased myocye 
proliferation. 
conclusion:  Our data suggests CSCs dose-dependently improve LV function and structure where a minimum of 0.75 M CSCs is required 
to exert therapeutic effects. Very high doses could be harmful.
